weight gain on glp 1 While nearly 18% of U.S. adults have taken a GLP-1 drug for loss or to treat a chronic condition, about half of people will stop taking it within a year. Often November Blog - What happens
Description
Rising obesity prevalence and expanding treatment guidelines favoring GLP-1 therapies are accelerating adoption

Fourniers gangrene (severe genital infection): A very rare but serious infection in the genital area

Please click the button below

Injection site reactions are a common side effect of GLP-1s like semaglutide or tirzepatide, affecting around 1% to 8% of people taking the medications
The combination of HRT and GLP-1 medications represents a new era in womens healthone that treats both the hormonal and metabolic sides of midlife weight gain
